Document is current
Any future updates will be listed below
-
Authors
Vega-Beyhart, Arturo https://orcid.org/0000-0003-0373-1573
Iruarrizaga, Marta
Pané, Adriana
García-Eguren, Guillermo
Giró, Oriol
Boswell, Laura
Aranda, Gloria
Flores, Vanesa
Casals, Gregori
Alonso, Cristina
Mora, Mireia
Halperin, Irene
Carmona, Francesc
Enseñat, Joaquim
Vidal, Oscar
Hu, Ting
Rojo, Gemma
Gomis, Ramon
Hanzu, Felicia A https://orcid.org/0000-0002-2399-4023
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (FIS PI1500859)
Instituto de Salud Carlos III (PIE14/00031)
- License Information
-
More Information
Article History
Received: 2 October 2020
Revised: 8 March 2021
Accepted: 6 April 2021
First Online: 21 April 2021
Declarations
:
: The present study followed international and national regulations including the Declaration of Helsinki and national notes for guidance on Good Clinical Practice CPMP/ICH/135/95. The Institutional Research and Ethics Committee at Hospital Clínic de Barcelona approved the present study (<i>Comité de Ética de la Investigación con medicamentos del Hospital Clínic de Barcelona</i>). The Institutional Research and Ethics Committee at Hospital Regional Universitario de Málaga approved the present study (<i>Comité de Ética de la Investigación Provincial de Málaga</i>).
: Written informed consent was obtained from all participants prior to study inclusion and are available under considerable request.
: Not applicable. No personal nor any clinical details of participants are presented.
: The authors declare no competing interests.
